UNSPSC 51294209: Indeloxazine hydrochloride

This classification denotes an antidepressant agent with the molecular structure C14H17NO2.CLH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, 15QZ6NE84E chemically known as morpholine, 2-((1h-inden-7-yloxy)methyl)-, hydrochloride, (+/-)-, but more commonly known as indeloxazine hydrochloride, which bears US NIH Compound Identifier 47517. European Medicines Agency schedules Indeloxazine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02663MIG.

UNSPSC 51294209 Indeloxazine hydrochloride is a Commodity code that in practice captures pharmaceutical and medical countermeasure procurement by state and local health agencies. The recent solicitation activity under this code reflects state and local government purchase of opioid-overdose reversal agents and related harm-reduction equipment rather than the specific pharmaceutical compound named in the code taxonomy. Issuing bodies pursuing these goods include county health departments and public health authorities executing community health and emergency-response initiatives, often with funding tied to federal public health programs or disaster-response appropriations that carry compliance requirements beyond standard state procurement.

Seminole County, Florida posted the most recent relevant opportunity under this code—IFB 60459723LAS, an Invitation for Bid released June 30, 2026, with a response deadline of July 26, 2023, seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems for annual procurement with quarterly deliveries to the Seminole County Community Health Building in Sanford. The solicitation required electronic bid submission through the county's e-Procurement Portal, with bidders responsible for all shipping and delivery costs, E-Verify compliance, drug-free workplace certification, and specified insurance coverage including workers' compensation and commercial general liability. The contract structure offered an initial two-year term with a one-year renewal option and included a three-month probationary termination period. The opportunity noted potential FEMA funding with associated federal compliance obligations under the Clean Air Act and Federal Water Pollution Control Act. No explicit set-aside designations for disadvantaged enterprises were stated in the procurement documents.